marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-12-2024
Agile Therapeutics Financial Ratios 2011-2024 | AGRX
Annual Financial Ratios Agile Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.0 | -0.0 | -4.8 | -10.0 | -1.5 | -3.6 | -2.2 | -4.4 | -6.2 | - | - | - |
P/S |
0.1 | 0.0 | 0.2 | 329.2 | - | - | - | - | - | - | - | - | - |
EPS |
-6.7 | -58.8 | -1464.2 | -0.6 | -0.4 | -0.6 | -0.9 | -1.0 | -1.4 | -1.4 | -289.4 | -603.8 | - |
EV (Enterprise Value) |
25.3 M | 14.8 M | 11.6 M | 256 M | 156 M | 23.3 M | 79.5 M | 36.7 M | 121 M | 77.8 M | 83.7 M | 66.1 M | - |
EBITDA per Share |
-9.17 | -119 | -1.42 K | -0.558 | -0.378 | -0.539 | -0.866 | -1.05 | -1.5 | -1.62 | - | - | - |
EV/EBITDA |
-18.5 | -5.1 | -8.2 | -1.1 | -2.8 | -1.0 | -3.5 | -4.0 | - | - | - | ||
PEG |
-0.0 | -0.0 | -0.0 | 0.08 | -0.29 | -0.04 | -0.33 | -0.09 | -2.08 | -0.54 | - | - | - |
P/B |
-0.1 | -0.0 | 0.1 | 5.0 | 4.1 | 1.4 | 2.8 | 1.5 | 4.5 | 2.8 | - | - | - |
P/CF |
-0.1 | -0.0 | -0.0 | -5.2 | -11.8 | -1.7 | -3.9 | -2.7 | -5.2 | -6.8 | - | - | - |
ROE % |
88.64 | 458.29 | -1815.25 | -105.12 | -40.67 | -98.04 | -77.92 | -67.96 | -101.99 | -44.65 | - | - | - |
ROA % |
-141.05 | -178.43 | -180.68 | -70.97 | -37.56 | -88.33 | -55.94 | -45.00 | -59.82 | -29.32 | - | - | - |
ROCE % |
121.85 | 947.81 | -1813.67 | -74.65 | -41.22 | -91.78 | -73.81 | -55.88 | -77.35 | -40.40 | - | - | - |
Current Ratio |
0.4 | 0.7 | 1.3 | 7.7 | 9.3 | 3.8 | 2.6 | 4.8 | 4.8 | 4.6 | - | - | - |
DSO |
63.1 | 82.3 | 106.7 | 421.5 | - | - | - | - | - | - | - | - | - |
DIO |
82.7 | 61.3 | 16.4 | - | - | - | - | - | - | - | - | - | - |
DPO |
351.8 | 438.9 | 214.1 | 5005.2 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
145.8 | 143.7 | 123.2 | 421.5 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-206.0 | -295.2 | -90.9 | -4583.6 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Agile Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.73 | 0.28 | - | -0.27 | -2.15 | -5.91 | - | -8.01 | -57.29 | -166.68 | - | 7.2 | -8 | -8 | -0.2 | -0.18 | -0.12 | -0.1 | -0.1 | -0.08 | -0.08 | -0.13 | -0.11 | -0.11 | -0.16 | -0.2 | -0.18 | -0.22 | -0.26 | -0.26 | -0.18 | -0.27 | -0.29 | -0.27 | -0.17 | -0.42 | -0.38 | -0.4 | -0.37 | -0.34 | -0.46 | 0.1 | -45.68 | -71.67 | -70.29 | -109.18 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.59 | - | - | - | -7.33 | - | -23.6 | -115 | -241 | - | -6.07 | -7.05 | -7.17 | - | -0.17 | -0.12 | -0.1 | - | -0.08 | -0.08 | -0.13 | - | -0.1 | -0.15 | -0.21 | - | -0.21 | -0.24 | -0.25 | - | -0.25 | -0.27 | -0.26 | - | -0.4 | -0.36 | -0.33 | - | -0.32 | -0.44 | -23 | - | -64.3 | -63 | - | - | - | - | - | - | - | - | - |
ROE % |
54.62 | 31.86 | 95.00 | 291.03 | 480.62 | 231.05 | 171.70 | 14.66 | -338.41 | -191.93 | -277.57 | -313.29 | -187.72 | -138.00 | -105.12 | -82.56 | -60.78 | -46.45 | -40.67 | -46.40 | -55.50 | -74.38 | -98.04 | -96.34 | -97.09 | -91.10 | -77.92 | -73.04 | -71.94 | -71.35 | -67.96 | -68.77 | -81.96 | -90.59 | -101.99 | -107.89 | -93.89 | -75.69 | -44.65 | -22.27 | 0.54 | 15.93 | 13.60 | 10.23 | 5.07 | - | - | - | - | - | - | - | - | - |
ROA % |
-83.84 | -34.79 | -76.99 | -109.11 | -133.89 | -119.33 | -83.30 | -129.03 | -142.63 | -160.63 | -108.26 | -132.37 | -107.90 | -88.98 | -70.97 | -59.01 | -46.71 | -38.92 | -37.56 | -42.42 | -50.41 | -67.24 | -88.33 | -83.65 | -80.75 | -71.60 | -55.94 | -51.75 | -49.94 | -48.40 | -45.00 | -44.59 | -51.04 | -54.69 | -60.16 | -64.91 | -57.84 | -47.79 | -29.32 | -33.53 | -47.56 | -65.91 | -67.44 | -50.75 | -25.13 | - | - | - | - | - | - | - | - | - |
ROCE % |
103.70 | 133.45 | 145.62 | 764.07 | 1350.29 | 826.87 | 427.96 | 280.27 | -485.88 | -72.41 | -261.64 | -291.35 | -173.36 | -126.05 | -65.50 | -75.34 | -55.46 | -42.87 | -27.88 | -45.80 | -53.88 | -71.64 | -78.36 | -96.81 | -97.34 | -91.08 | -57.33 | -74.10 | -72.41 | -71.70 | -51.81 | -81.96 | -95.33 | -103.62 | -80.43 | -97.23 | -83.89 | -66.76 | -33.30 | -28.65 | -7.21 | 7.05 | 9.20 | 9.20 | 4.55 | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.4 | 0.6 | 0.4 | 0.5 | 0.5 | 0.6 | 0.7 | 1.5 | 1.1 | 1.1 | 1.3 | 1.4 | 1.9 | 2.4 | 3.1 | 3.1 | 3.1 | 3.1 | 13.1 | 13.1 | 13.1 | 13.1 | 10.1 | - | - | - | 3.5 | - | - | - | 3.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
76.6 | 65.5 | - | 54.7 | 62.9 | 77.8 | - | 88.1 | 80.5 | 82.9 | - | 87.8 | 57.3 | 466.9 | 105.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
291.0 | 176.2 | - | 91.1 | 93.9 | 80.7 | - | 132.5 | 102.9 | 109.3 | - | 116.5 | 201.3 | 66.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
889.4 | 602.7 | - | 240.1 | 326.6 | 412.1 | - | 542.4 | 441.2 | 545.1 | - | 202.7 | 492.3 | 385.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
367.6 | 241.6 | - | 145.8 | 156.8 | 158.5 | - | 220.6 | 183.4 | 192.2 | - | 204.3 | 258.6 | 533.3 | 105.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-521.8 | -361.1 | - | -94.3 | -169.8 | -253.6 | - | -321.9 | -257.7 | -352.9 | - | 1.6 | -233.6 | 147.7 | 105.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency